MoneyWorks4Me

Zydus Lifesciences informs about updates on buy back

18 Jun 2026 Evaluate
Zydus Lifesciences has informed about submission of the post buyback public advertisement pertaining to buyback of not exceeding 87,30,158 fully paid-up equity shares having face value of Rs 1 each (Equity Shares) of Zydus Lifesciences at a price of Rs 1,260 per Equity Share for an aggregate amount not exceeding Rs 1100,00,00,000 (Buyback Size), on a proportionate basis through tender offer route (Buyback), pursuant to the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (Buyback Regulations).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..